LIA
SCMP

LS Investment Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

LS Investment Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-808
Closed -$15K – 1909
2017
Q4 		$15K Sell
808
-5,796
-88% -$71.4K ﹤0.01% 1626
2017
Q3 		$78K Buy
6,604
+1,639
+33% +$18.4K ﹤0.01% 1225
2017
Q2 		$52K Buy
4,965
+3,925
+377% +$40K ﹤0.01% 1336
2017
Q1 		$11K Buy
+1,040
New +$12.1K ﹤0.01% 1682

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

LS Investment Advisors's SCMP Position: Q1 2018 in Review

LS Investment Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 808 shares — an estimated $15K sold.

LS Investment Advisors first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $78K in Q3 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • LS Investment Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • LS Investment Advisors sold 808 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $15K.
  • LS Investment Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
  • LS Investment Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $78K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on LS Investment Advisors's 13F filing for Q1 2018, filed 8 May 2018.